Answers are grounded in this paper and cite their sources.
Background: Primary cutaneous aspergillosis attributable to Aspergillus terreus represents an uncommon opportunistic fungal infection predominantly observed in immunocompromised individuals; however, it can also manifest in immunocompetent patients subsequent to trauma or invasive interventions. Case Presentation: We present a case of a 16-year-old male with juvenile diabetes mellitus who developed primary cutaneous aspergillosis marked by a painful, erythematous keloid scar on the chin accompanied by purulent discharge. The patient's medical history includes a recent intralesional steroid injection three weeks before presentation, keloid formation, and surgical excision of a mole nine months prior. Direct microscopic examination of aspirated pus revealed septate, acute-angle branching hyaline hyphae indicative of Aspergillus species. Fungal culture yielded cinnamon-brown, suede-like colonies, and the isolate was microscopically identified as Aspergillus terreus, a diagnosis further substantiated by gene sequencing demonstrating 99% homology. Early diagnosis and treatment with oral itraconazole and topical terbinafine resulted in clinical improvement. Conclusion: This case highlights Aspergillus terreus as a rare cause of primary cutaneous aspergillosis, emphasising early microbiological diagnosis and timely antifungal treatment in patients with diabetes.
No takes yet. Share an insight, caveat, or question.
Nimmala et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: